logo
Yes, You Can Die From a Broken Heart

Yes, You Can Die From a Broken Heart

Medscape14-05-2025

This transcript has been edited for clarity.
Welcome to Impact Factor , your weekly dose of commentary on a new medical study. I'm Dr F. Perry Wilson from the Yale School of Medicine.
A patient comes crashing into the emergency room with severe chest pain. The EKG looks like this:
As a doctor, if you see this, you're calling the cardiac cath lab. This is an ST-elevation myocardial infarction — the big one — indicative of a blood clot blocking blood flow to a large section of the heart. The sooner you get that blood clot out, the better chance the patient has to survive.
So the patient is rushed to the cath lab, and they find… nothing. Clear coronaries. No blood clot. Further questioning reveals that the patient, an older woman, lost her husband recently. This is stress-induced cardiomyopathy, medically known as Takotsubo cardiomyopathy (TC). It's the pathophysiologic manifestation of a broken heart.
First described in 1991, Takotsubo syndrome occurs in the setting of deep psychological, emotional, or physical stress.
Despite being aware of it for decades, we still don't really understand what the underlying processes are, though they probably have something to do with an excess of catecholamines. But a new study cobbles together data from across the United States to give us new insight into the epidemiology and outcomes of the syndrome.
Interestingly, women are much more likely to get a broken heart. But men are more likely to die from it.
We got a nice Takotsubo analysis this week, thanks to this article in the Journal of the American Heart Association , from Mohammad Movahed of the University of Arizona and colleagues.
They used a database called the National Inpatient Sample. It is what it sounds like: a sample of data from patients hospitalized around the nation. It's a weighted dataset; it doesn't have data from every hospitalization, but individual patients in the dataset can stand in for those who aren't there. This allows you to estimate stuff like the total number of admissions for a certain diagnosis across the whole country.
The researchers flagged admissions with a diagnosis code for TC. All told, they identified 39,984 individuals with the syndrome, which scales up to an estimated 199,890 US admissions in total from 2016-2020 — about 40,000 admissions per year in this country. It's not a huge number; there are around 600,000 admissions per year for acute myocardial infarction, but it's not exactly rare.
Women were much more likely to have TC; 83% of all the cases were female. You can see here a slight increase in prevalence over time, but nothing dramatic, especially considering that the last year of data would encompass the start of the COVID pandemic.
If we break down the incidence by age group, you can see an interesting increase in risk as people got older, with a near doubling of risk after age 45.
People have hypothesized that estrogen may play a protective role in this condition, so we might be seeing an increased risk associated with menopause here, but I would have liked to see this stratified by sex to be certain.
The authors compare outcomes among those hospitalized with TC to outcomes of hospitalized patients without TC. That feels like an overly broad control group, to be honest, so it isn't surprising that there is, for example, a 12-fold risk for cardiogenic shock compared with the general inpatient population. Individuals admitted to the hospital with other types of heart disease, or a heart attack, would have told us a bit more about the unique risks of TC. Maybe next time.
Of course, the worst possible outcome is death, and 6.58% of the patients with TC died during their admission. That's against a background rate of 2.4% of all other patients in the hospital — about a threefold increase in mortality risk.
But men with TC were much more likely to die than women, with an 11.2% mortality rate compared with 5.5% among women. This has also been increasing over time. There's no clear explanation for the discrepancy. Men were more likely to develop the condition from physical, as opposed to emotional, stress, and that might change the risk profile. Alternatively, it's possible that this is a 'stubborn man' phenomenon; men might be less likely to go to the hospital when symptoms are mild, so if they do make it to the hospital, they are in worse shape. Take care of yourselves, guys.
This paper may have raised more questions than answers, but I appreciate the opportunity to highlight something we often forget — that there is a profound connection between our minds, our emotions, and our bodies, and that connection is not purely subjective. Takotsubo cardiomyopathy is a potentially fatal disease, with all the risks of a major heart attack and without a convenient treatment like cardiac catheterization. And though I hope most of us never experience the levels of stress — emotional or otherwise — that would precipitate this disease, the very existence of a syndrome like this shows us that stress can be toxic. None of us can live stress-free lives, of course, and I'm not sure what the dose-response effect is, but in the end, perhaps knowing that how we feel affects how we feel can help us better manage how we feel.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Why men with broken heart syndrome are more likely to die than women
Why men with broken heart syndrome are more likely to die than women

CNN

time4 hours ago

  • CNN

Why men with broken heart syndrome are more likely to die than women

Heart disease Chronic diseasesFacebookTweetLink Follow Get inspired by a weekly roundup on living well, made simple. Sign up for CNN's Life, But Better newsletter for information and tools designed to improve your well-being. A 59-year-old man arrived at the Peking University First Hospital in Beijing for a procedure when he started having severe chest pain and shortness of breath. Four months earlier, he had cancerous tumors removed from his bladder. Around his family, he tried his best to appear strong and avoided discussions of his health. Privately, his severe anxiety over the possibility of a cancer recurrence kept him awake at night. Doctors said the man was experiencing takotsubo cardiomyopathy — also known as broken heart syndrome, as documented in a 2021 case study. The rare stress-induced heart condition has been observed primarily in women, but a study published in the Journal of the American Heart Association in May found that the illness may be more deadly for the men who get it. Thought to be caused by extreme emotional or physical events — such as learning about the death of a loved one, winning the lottery or lifting a heavy sofa — takotsubo cardiomyopathy, or TC, occurs when the heart muscle is flooded with stress hormones, causing part of it to 'freeze' in place. As the heart struggles to properly pump blood, symptoms resemble those of a heart attack, including chest pain, heart palpitations and irregular heartbeat. The new study analyzed data from nearly 200,000 patients hospitalized for TC in the United States between 2016 and 2020. While women accounted for 83% of the cases, men were more than twice as likely to die from the condition — with a mortality rate of 11.2%. 'The differences between men and women are a very striking finding,' said study coauthor Dr. Mohammad Reza Movahed, a clinical professor of medicine at the University of Arizona in Tucson. 'It raises a new, interesting question that should really be studied.' Similar to differences between men's and women's cardiovascular health more generally, the discrepancies in TC death rates are not well understood, Movahed said, especially because they counter trends in other heart diseases. It's widely theorized, however, that differences in hormone levels play a role. Stressful situations trigger the adrenal glands to release our fight-or-flight hormones, called catecholamines. They are meant to increase our blood pressure and raise our heart rate, but extreme levels can temporarily 'stun' cells in the heart's tissue, leading to TC, Movahed explained. Men are thought to produce more catecholamines during stressful situations compared with women, possibly leading men to present with more severe cases of TC, he suggested. Estrogen, a sex hormone produced at higher levels in women, may also have a protective effect on the cardiovascular system, making it easier to manage an extreme influx of catecholamines and reducing the risk of severe complications from TC, said Dr. Louis Vincent, a noninvasive-cardiology research fellow at the University of Miami, who coauthored a similar, multiyear study investigating discrepancies in men and women who had TC. Vincent was not involved in the new study. Beyond biological differences, social factors may play a role as well. 'Most (physicians) know about takotsubo, but they may think of it as a disease just affecting women, so the diagnosis might be overlooked in men,' said Dr. Deepak Bhatt, a cardiologist and the director of Mount Sinai Fuster Heart Hospital who was not involved in the study. 'With misdiagnosis, care is delayed, and that can sometimes lead to worse outcomes.' Men may also seek care at a later stage of illness, believing that their symptoms are manageable or may pass, said Dr. Alejandro Lemor, an assistant professor of interventional cardiology at the University of Mississippi Medical Center who was also not involved in the study. Deadly complications from TC include blood clots, stroke, cardiac arrest and heart failure, Lemor said. If the condition is caught early, medications can reduce the risk of having these complications, restore proper heart function and allow for full recovery within weeks, he added. Movahed's team was able to factor for important variables like age, race, income, chronic lung disease, hypertension and diabetes in the findings. However, there was no patient data on other comorbid diseases, such as a history of stroke or the presence of a Covid-19 infection, Vincent said. Additionally, the new study included in-patient diagnostic data only for those hospitalized with TC, so those who received outpatient care or died later from complications outside the hospital were likely not counted in the analysis, Movahed noted. To establish a firmer explanation for the differences in mortality rates between men and women and further test treatment methods, a more detailed dataset would be needed, Vincent said. 'People should be aware in studies like this, we're presenting findings that are based on diagnostic codes, and we're not looking at patient procedures or lab results,' Vincent said. 'But it's powerful in the sense that it lets us look at large populations and look at trends. And I think that this trend of a higher mortality in men is worth taking a deeper look into.' Sudden, severe chest pain or shortness of breath should always be treated as a medical emergency, warned Bhatt, who is also a professor of cardiovascular medicine at the Icahn School of Medicine at Mount Sinai in New York City. 'It's not a time to tough it out at home or get on the internet to figure it out. … Don't try to track down your primary care provider. Call emergency services,' Bhatt said. 'Time matters. By winning those few hours, you could save yourself irreparable damage to your heart.' Symptoms following physical stressors — a common cause of TC in men — should not be ignored, Movahed said, especially preceding medical events such as asthma attacks, seizures or complications from drug use. And while TC is caused by sudden stress, Bhatt said that managing chronic stress with daily meditation or exercise can lead to better cardiovascular health overall while giving you routines to fall back on in unexpected situations.

Unregulated chemical 13,000 times sweeter than sugar is used in most e-cigarettes: study
Unregulated chemical 13,000 times sweeter than sugar is used in most e-cigarettes: study

New York Post

time4 hours ago

  • New York Post

Unregulated chemical 13,000 times sweeter than sugar is used in most e-cigarettes: study

A little-known artificial sweetener that's up to 13,000 times sweeter than sugar is now used in most popular flavored e-cigarettes — even though it is not listed on labels and is only FDA-approved for food, a new study found. Neotame was detected in 57 of 73 flavored vaping products often marketed to kids and teens and had an average content nearly five times higher than in a mint candy, a study conducted by researchers from Yale School of Medicine and Duke University found. Little is known about the health effects of inhaling the potent, no-calorie alternative, which was created by NutraSweet and is also known as Newtame, and current regulations do not limit its use, according to the June 2 study published in the Journal of the American Medical Association. 3 Researchers at Yale detected the sweetener in a majority of flavored vaping products on the market. The researchers set out to prove, mainly to regulators and clinicians, how commonly the chemical, which is also up to 65 times sweeter than aspartame, is being used in newer products, they said. All popular disposable e-cigs introduced after 2021 that haven't yet received U.S. Food and Drug Administration marketing authorization — 27 devices across 11 different brands — contained neotame, according to the study. Among them were vapes from brands like Breeze Smoke, Elf Bar and Vapetasia, which offer flavors like Strawberry Apple, Killer Kustard and Blue Razz Ice. Products from three brands — Vuse and NJOY, which are FDA-approved, and JUUL, which is awaiting approval — that were introduced before 2021 do not contain it, the study found. The substance was likely chosen for its heat stability compared to other sweeteners, but its behavior when heated and vaporized in e-cigarettes is unknown, the scientists wrote in their findings. 3 Flavored e-cigarettes, often marketed to kids and teenagers, are rife with the artificial sweetener neotame. Vapetasia 'There are two specific concerns about the finding: How does it affect the potential for addiction to the product, and what are the product's adverse health effects when inhaled?' said Hanno Erythropel, the paper's lead author. 'Eating versus inhaling something is very different,' Erythropel, a Yale researcher, added. 'There are many examples in which chemicals are safe for eating but not for inhalation.' Neotame is approved by the FDA for use in food, but not in vaping products, according to the researchers. When eaten in foods like cakes, soft drinks and chewing gum, neotame can seriously damage gut health, a study published last year in the medical journal Frontiers found. 3 Neotame is an artificial sweetener similar to aspartame. luchschenF – 'The respiratory and systemic health effects of neotame and its potential decomposition products during heating in an e-cigarette are unknown,' the scientists said. Alarmingly, most of the 'funky' flavors used in e-cigarettes have not been evaluated for use in products other than food, Erythropel added. The team hopes its findings pave the wave for further studies on neotame toxicity and exposure once it is heated and inhaled, and how users rate the appeal of e-cigarettes that contain it.

Hundreds of pharmacies are set to close: How it could impact you
Hundreds of pharmacies are set to close: How it could impact you

The Hill

time5 hours ago

  • The Hill

Hundreds of pharmacies are set to close: How it could impact you

(NEXSTAR) — Several retail pharmacy chains have shuttered some of their stores this year, with more on the way for others, like Rite Aid, which filed for bankruptcy in May. It could create what some refer to as 'pharmacy deserts,' areas in which drugstores and the additional services they provide may not be available for miles. And in areas where other pharmacies are picking up the slack, it could have an impact on current customers. 'Closures of major chain pharmacies often create ripple effects across the community,' E. Michael Murphy, an assistant professor of clinical pharmacy at The Ohio State University, told Nexstar via email. Nearby pharmacies, independent or part of a chain, can see 'a sudden increase in patients,' he explained, which could 'lead to longer lines, and increase strain on the health care team.' It could also disrupt your medical care. Shuttering pharmacies in larger cities, like New York City and Philadelphia, may have limited impacts. Take, for example, a Rite Aid located in Philadelphia that has been designated for closure. A three-minute walk down the road will take you to a Walgreens and a local pharmacy. Within smaller communities, that may not be the case. Customers may need to drive to a nearby town to pick up their prescriptions, which 'could have some negative consequences on their adherence to their medication,' Lucas A. Berenbrok, an associate professor at the University of Pittsburgh School of Pharmacy, explained to Nexstar. 'For those without reliable transportation, especially older adults or people with disabilities, traveling even a few extra miles can be a serious barrier,' Murphy said. That could lead to delayed access to prescriptions and missed dosages. Closing pharmacies also reduces health access points for people. In addition to filling prescriptions, pharmacies are able to provide vaccines, chronic disease management, urgent consultations, over-the-counter treatments, and certain health tests. 'There's a lot more going on at the pharmacy now than ever before,' Berenbrok explained, outlining how pharmacists helped to administer the COVID vaccine during the pandemic, for example, and the additional services they can provide in some states. He went on to explain that while online pharmacies can help fill the void of shuttered drugstores, they're largely unable to accommodate the additional services pharmacies provide. 'They also assume reliable internet access, digital literacy, and stable housing, which are barriers for many vulnerable patients,' Murphy said. 'For communities losing local pharmacies, online options may fill part of the gap but cannot replace the full range of services a community pharmacist provides.' Berenbrok agreed that mail-order pharmacies have 'a time and place' because of their convenience, but they require planning ahead, which may not be useful for certain medications like antibiotics. If your pharmacy is closing soon, Murphy recommended being proactive and asking your pharmacist where your prescriptions are being sent and whether that pharmacy has your insurance and medication history. He also encouraged asking for a 90-day supply or mail-order option for prescriptions if transportation is a concern. Chains poised to take on former Rite Aid clients, like CVS and Walgreens, say they're prepared to welcome new customers. Even if your prescriptions are not moving to a new pharmacy, you may want to make sure your prescription is being filled a day or two before you need it rather than the same day that your current supply runs out, Berenbrok said. Then, if you're short on time and facing a long line, you won't miss a dose. Murphy also suggested contacting elected officials and urging them to take action. 'While pharmacists are committed to stepping up to meet the need, without adequate state and federal policy changes to address the broken business model that caused the pharmacy to close in the first place, we will continue to see pharmacies close and patients having to navigate the loss of their trusted health care professional.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store